856667-80-6 Usage
General Description
Pyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid, 4-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methyl- is a chemical compound with a complex structure. It consists of a pyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid core, with a 4-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methyl- functional group attached. Pyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid, 4-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methyl- is a potential drug candidate with pharmaceutical applications, and its unique structure may confer specific biological activities or properties. The compound's structure suggests it may have interactions with various biological targets, making it an interesting subject for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 856667-80-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,6,6,6 and 7 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 856667-80:
(8*8)+(7*5)+(6*6)+(5*6)+(4*6)+(3*7)+(2*8)+(1*0)=226
226 % 10 = 6
So 856667-80-6 is a valid CAS Registry Number.
856667-80-6Relevant articles and documents
Hetero-aromatic compound and its use in medicine
-
Paragraph 1399; 1408-1409, (2019/07/04)
The invention provides a hetero-aromatic compound or a stereisomer, geometric isomer, tautomer, despinner, nitrogen oxide, hydrate, solvate, metabolite, metabolism precursor and pharmaceutically acceptable salt or prodrug thereof, which is used for treating proliferative diseases. The invention also discloses a pharmaceutical composition containing the compound and an application of the compound or pharmaceutical composition thereof in preparation of a medicine for treating proliferative diseases.
SYNTHETIC PROCESS
-
Page/Page column 35-36, (2008/06/13)
The present invention provides a process for preparing compounds of formula (I) ["insert chemical structure here"](I)or a pharmaceutically acceptable salt thereof. The compounds prepared by the process of the invention inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.